Hypocholesterolemic efficacy of royal jelly in healthy mild hypercholesterolemic adults

摘要

Abstract Context: Royal jelly (RJ) has been reported for its health promoting factors such as antioxidant, anti-inflammatory and lipid lowering activities. Objective: The present randomized, placebo-controlled study examines the hypolipidemic beneficial effect of RJ through evaluating anthropometric measurements, lipid profile and various hormone levels in mildly hypercholesterolemic participants. Materials and methods: Forty subjects with mild hypercholesterolemia (180–200?mg/dL) were randomly selected and divided into two groups as experimental or placebo, who requested to intake nine capsules (350?mg/capsule) of RJ or placebo/day, respectively, for three months with one month of follow-up without any supplementation. Results: No significant changes were noted in any of the anthropometric parameters like body weight, waist and body fat. The serum total cholesterol (TC; 207.05–183.15?mg/dL) and low-density lipoprotein cholesterol (LDL-c; 126.44–120.31?mg/dL) levels were reduced significantly (p?p?